These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
(Address of principal executive offices)
|
Zip Code
|
|
(
|
||
|
Registrant’s telephone number, including area code
|
|
Not Applicable
|
||
|
Former name, former address and former fiscal year, if changed since last report
|
||
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
|
|
|
|
||
|
|
|
|
|
|
Accelerated filer
☐
|
|
Non-accelerated filer
☐
|
Smaller reporting company
|
|
Emerging growth company
|
|
Item 1.
|
Financial Statements
|
|||
|
5
|
||||
|
6
|
||||
|
7
|
||||
|
8
|
||||
|
9
|
||||
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
||||
|
10
|
||||
|
11
|
||||
|
11
|
||||
|
12
|
||||
|
15
|
||||
|
16
|
||||
|
17
|
||||
|
18
|
||||
|
18
|
||||
|
19
|
||||
|
20
|
||||
|
20
|
||||
|
21
|
||||
|
21
|
||||
|
22
|
||||
|
22
|
||||
|
23
|
||||
|
24
|
||||
|
Item 2.
|
25
|
|||
|
Item 3.
|
37
|
|||
|
Item 4.
|
38
|
|||
|
PART II
-
OTHER INFORMATION
|
||||
|
Item 1.
|
39
|
|||
|
Item 1A.
|
39
|
|||
|
Item 2.
|
39
|
|||
|
Item 6.
|
40
|
|||
|
41
|
||||
| ● |
Adjusted Earnings Per Share (Adjusted EPS);
|
| ● |
Free Cash Flow less Product Development Spending;
|
| ● |
Adjusted Contribution to Profit and margin;
|
| ● |
Adjusted Income Before Taxes;
|
| ● |
Adjusted Income Tax Provision;
|
| ● |
Adjusted Effective Tax Rate;
|
| ● |
EBITDA, Adjusted EBITDA and margin;
|
| ● |
Organic revenue; and
|
| ● |
Results on a constant currency basis.
|
| ● |
Adjusted EPS, Adjusted Contribution to Profit, Adjusted Income Before Taxes, Adjusted Income Tax Provision, Adjusted Effective Tax Rate, Adjusted EBITDA, and organic revenue (excluding acquisitions) provide a more comparable basis to analyze operating results and earnings and are measures commonly used by shareholders to measure our performance.
|
| ● |
Free Cash Flow less Product Development Spending helps assess our ability, over the long term, to create value for our shareholders as it represents cash available to repay debt, pay common stock dividends, and fund share repurchases and acquisitions.
|
| ● |
Results on a constant currency basis removes distortion from the effects of foreign currency movements to provide better comparability of our business trends from period to period. We measure our performance excluding the impact of foreign currency (or at constant currency), which means that we apply the same foreign currency exchange rates for the current and equivalent prior period.
|
|
July 31, 2021
|
April 30, 2021
|
|||||||
|
Assets:
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Accounts receivable, net of allowance for credit losses of $
|
|
|
||||||
|
Inventories, net
|
|
|
||||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Product development assets, net
|
|
|
||||||
|
Royalty advances, net
|
|
|
||||||
|
Technology, property and equipment, net
|
|
|
||||||
|
Intangible assets, net
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Operating lease right-of-use assets
|
|
|
||||||
|
Other non-current assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
Liabilities and shareholders' equity:
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable
|
$
|
|
$
|
|
||||
|
Accrued royalties
|
|
|
||||||
|
Short-term portion of long-term debt
|
|
|
||||||
|
Contract liabilities
|
|
|
||||||
|
Accrued employment costs
|
|
|
||||||
|
Accrued income taxes
|
|
|
||||||
|
Short-term portion of operating lease liabilities
|
|
|
||||||
|
Other accrued liabilities
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Long-term debt
|
|
|
||||||
|
Accrued pension liability
|
|
|
||||||
|
Deferred income tax liabilities
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Other long-term liabilities
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Shareholders’ equity
|
||||||||
|
Preferred stock, $
|
|
|
||||||
|
Class A common stock, $
|
|
|
||||||
|
Class B common stock, $
|
|
|
||||||
|
Additional paid-in-capital
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
|
Accumulated other comprehensive loss, net of tax
|
(
|
)
|
(
|
)
|
||||
|
Less treasury shares at cost (Class A –
|
(
|
)
|
(
|
)
|
||||
|
Total shareholders’ equity
|
|
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
|
$
|
|
||||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Revenue, net
|
$
|
|
$
|
|
||||
|
Costs and expenses
|
||||||||
|
Cost of sales
|
|
|
||||||
|
Operating and administrative expenses
|
|
|
||||||
|
Restructuring and related (credits) charges
|
(
|
)
|
|
|||||
|
Amortization of intangible assets
|
|
|
||||||
|
Total costs and expenses
|
|
|
||||||
|
Operating income
|
|
|
||||||
|
Interest expense
|
(
|
)
|
(
|
)
|
||||
|
Foreign exchange transaction gains (losses)
|
|
(
|
)
|
|||||
|
Gain on sale of certain assets
|
|
|
||||||
|
Other income, net
|
|
|
||||||
|
Income before taxes
|
|
|
||||||
|
Provision for income taxes
|
|
|
||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Earnings per share:
|
||||||||
|
Basic
|
$
|
|
$
|
|
||||
|
Diluted
|
$
|
|
$
|
|
||||
|
Weighted average number of common shares outstanding:
|
||||||||
|
Basic
|
|
|
||||||
|
Diluted
|
|
|
||||||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Other comprehensive (loss) income:
|
||||||||
|
Foreign currency translation adjustment
|
(
|
)
|
|
|||||
|
Unamortized retirement credits (costs), net of tax (expense) benefit of $(
|
|
(
|
)
|
|||||
|
Unrealized gain on interest rate swaps, net of tax (expense) of $(
|
|
|
||||||
|
Total other comprehensive (loss) income
|
(
|
)
|
|
|||||
|
Comprehensive income
|
$
|
|
$
|
|
||||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Operating activities
|
||||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
|
Amortization of intangible assets
|
|
|
||||||
|
Amortization of product development assets
|
|
|
||||||
|
Depreciation and amortization of technology, property and equipment
|
|
|
||||||
|
Restructuring and related (credits) charges
|
(
|
)
|
|
|||||
|
Stock-based compensation expense
|
|
|
||||||
|
Employee retirement plan expense
|
|
|
||||||
|
Foreign exchange transaction (gains) losses
|
(
|
)
|
|
|||||
|
Gain on sale of certain assets
|
(
|
)
|
|
|||||
|
Other noncash charges
|
|
|
||||||
|
Net change in operating assets and liabilities
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
|
Investing activities
|
||||||||
|
Product development spending
|
(
|
)
|
(
|
)
|
||||
|
Additions to technology, property and equipment
|
(
|
)
|
(
|
)
|
||||
|
Businesses acquired in purchase transactions, net of cash acquired
|
(
|
)
|
(
|
)
|
||||
|
Proceeds related to the sale of certain assets
|
|
|
||||||
|
Acquisitions of publication rights and other
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
|
Financing activities
|
||||||||
|
Repayments of long-term debt
|
(
|
)
|
(
|
)
|
||||
|
Borrowings of long-term debt
|
|
|
||||||
|
Purchases of treasury shares
|
(
|
)
|
|
|||||
|
Change in book overdrafts
|
(
|
)
|
(
|
)
|
||||
|
Cash dividends
|
(
|
)
|
(
|
)
|
||||
|
Impact of tax withholding on stock-based compensation and other
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by financing activities
|
|
|
||||||
|
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
|
(
|
)
|
|
|||||
|
Cash reconciliation:
|
||||||||
|
Cash and cash equivalents
|
|
|
||||||
|
Restricted cash included in Prepaid expenses and other current assets
|
|
|
||||||
|
Balance at beginning of period
|
|
|
||||||
|
(Decrease)/increase for the period
|
(
|
)
|
(
|
)
|
||||
|
Cash and cash equivalents
|
|
|
||||||
|
Restricted cash included in Prepaid expenses and other current assets
|
|
|
||||||
|
Balance at end of period
|
$
|
|
$
|
|
||||
|
Cash paid during the period for:
|
||||||||
|
Interest
|
$
|
|
$
|
|
||||
|
Income taxes, net of refunds
|
$
|
|
$
|
|
||||
|
|
Class A common stock
|
Class B common stock
|
Additional
paid-in capital
|
Retained
earnings
|
Accumulated other comprehensive loss, net of tax
|
Treasury stock
|
Total
shareholders' equity
|
|||||||||||||||||||||
|
Balance at April 30, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Restricted shares issued under stock-based compensation plans
|
|
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||||||||||||
|
Impact of tax withholding on stock-based compensation and other
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Stock-based compensation expense
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Purchase of treasury shares
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Class A common stock dividends ($
|
|
—
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
|
Class B common stock dividends ($
|
—
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
|
Common stock class conversions
|
|
(
|
)
|
|
|
|
|
|
||||||||||||||||||||
|
Comprehensive income, net of tax
|
|
|
|
|
(
|
)
|
|
|
||||||||||||||||||||
|
Balance at
July 31, 2021
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
|
Class A common stock
|
Class B common stock
|
Additional
paid-in capital
|
Retained
earnings
|
Accumulated other
comprehensive loss, net of tax
|
Treasury stock
|
Total
shareholders' equity
|
|||||||||||||||||||||
|
Balance at April 30, 2020
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Cumulative effect of change in accounting principle, net of tax
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
|
Restricted shares issued under stock-based compensation plans
|
|
|
(
|
)
|
|
|
|
|
||||||||||||||||||||
|
Impact of tax withholding on stock-based compensation and other
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Stock-based compensation expense
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Class A common stock dividends ($
|
|
—
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
|
Class B common stock dividends ($
|
—
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
|
Common stock class conversions
|
|
(
|
)
|
|
|
|
|
|
||||||||||||||||||||
|
Comprehensive income, net of tax
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Balance at
July 31, 2020
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Research Publishing & Platforms:
|
||||||||
|
Research Publishing
|
$
|
|
$
|
|
||||
|
Research Platforms
|
|
|
||||||
|
Total Research Publishing & Platforms
|
|
|
||||||
|
Academic & Professional Learning:
|
||||||||
|
Education Publishing
(1)
|
|
|
||||||
|
Professional Learning
|
|
|
||||||
|
Total Academic & Professional Learning
|
|
|
||||||
|
Education Services:
|
||||||||
|
University Services
(2)
|
|
|
||||||
|
Talent Development Services
(1)(3)
|
|
|
||||||
|
Total Education Services
|
|
|
||||||
|
Total Revenue
|
$
|
|
$
|
|
||||
| (1) |
|
| (2) |
|
| (3) |
|
|
|
July 31, 2021
|
April 30, 2021
|
Increase/
(Decrease)
|
|||||||||
|
Balances from contracts with customers:
|
||||||||||||
|
Accounts receivable, net
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Contract liabilities
(1)
|
|
|
(
|
)
|
||||||||
|
Contract liabilities (included in Other long-term liabilities)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
| (1) |
|
|
|
July 31, 2021
|
April 30, 2021
|
||||||
|
Operating lease ROU assets
|
$
|
|
$
|
|
||||
|
Short-term portion of operating lease liabilities
|
|
|
||||||
|
Operating lease liabilities, non-current
|
$
|
|
$
|
|
||||
|
Three Months Ended
July 31,
|
||||||||
|
|
2021
|
2020
|
||||||
|
Operating lease cost
|
$
|
|
$
|
|
||||
|
Variable lease cost
|
|
|
||||||
|
Short-term lease cost
|
|
|
||||||
|
Sublease income
|
(
|
)
|
(
|
)
|
||||
|
Total net lease cost
(1)
|
$
|
|
$
|
|
||||
| (1) |
|
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Weighted-average remaining contractual lease term (years)
|
|
|
||||||
|
Weighted-average discount rate
|
|
%
|
|
%
|
||||
|
Cash paid for amounts included in the measurement of lease liabilities:
|
||||||||
|
Operating cash flows from operating leases
|
$
|
|
$
|
|
||||
|
Fiscal Year
|
Operating Lease
Liabilities
|
|||
|
2022 (remaining 9 months)
|
$
|
|
||
|
2023
|
|
|||
|
2024
|
|
|||
|
2025
|
|
|||
|
2026
|
|
|||
|
Thereafter
|
|
|||
|
Total future undiscounted minimum lease payments
|
|
|||
|
Less: Imputed interest
|
|
|||
|
Present value of minimum lease payments
|
|
|||
|
Less: Current portion
|
|
|||
|
Noncurrent portion
|
$
|
|
||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Restricted Stock
:
|
||||||||
|
Awards granted (shares)
|
|
|
||||||
|
Weighted average fair value of grant
|
$
|
|
$
|
|
||||
|
Expected life of options (years)
|
|
|||
|
Risk-free interest rate
|
|
%
|
||
|
Expected volatility
|
|
%
|
||
|
Expected dividend yield
|
|
%
|
||
|
Fair value of common stock on grant date
|
$
|
|
||
|
Exercise price of stock option grant
|
$
|
|
|
|
Foreign
Currency Translation
|
Unamortized
Retirement Costs
|
Interest
Rate Swaps
|
Total
|
||||||||||||
|
Balance at
April 30, 2021
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other comprehensive (loss) income before reclassifications
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
Amounts reclassified from Accumulated other comprehensive loss
|
|
|
|
|
||||||||||||
|
Total other comprehensive (loss) income
|
(
|
)
|
|
|
(
|
)
|
||||||||||
|
Balance at
July 31, 2021
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Balance at April 30, 2020
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other comprehensive income (loss) before reclassifications
|
|
(
|
)
|
(
|
)
|
|
||||||||||
|
Amounts reclassified from Accumulated other comprehensive loss
|
|
|
|
|
||||||||||||
|
Total other comprehensive income (loss)
|
|
(
|
)
|
|
|
|||||||||||
|
Balance at July 31, 2020
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Weighted average shares outstanding
|
|
|
||||||
|
Less: Unvested restricted shares
|
|
(
|
)
|
|||||
|
Shares used for basic earnings per share
|
|
|
||||||
|
Dilutive effect of unvested restricted stock units and other stock awards
|
|
|
||||||
|
Shares used for diluted earnings per share
|
|
|
||||||
|
Antidilutive options to purchase Class A common shares, restricted shares, warrants to purchase Class A common shares, and contingently issuable restricted stock which are excluded from the table above
|
|
|
||||||
|
|
Three Months Ended
July 31,
|
Total Charges
|
||||||||||
|
2021
|
2020
|
Incurred to Date
|
||||||||||
|
(Credits) Charges by Segment:
|
||||||||||||
|
Research Publishing & Platforms
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Academic & Professional Learning
|
|
(
|
)
|
|
||||||||
|
Education Services
|
(
|
)
|
|
|
||||||||
|
Corporate Expenses
|
(
|
)
|
|
|
||||||||
|
Total Restructuring and Related (Credits) Charges
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
(Credits) Charges by Activity:
|
||||||||||||
|
Severance and termination benefits
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Impairment of operating lease ROU assets and property and equipment
|
|
|
|
|||||||||
|
Acceleration of expense related to operating lease ROU assets and property and equipment
|
|
|
|
|||||||||
|
Facility related charges, net
|
|
|
|
|||||||||
|
Other activities
|
|
|
|
|||||||||
|
Total Restructuring and Related (Credits) Charges
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
|
April 30, 2021
|
(Credits)
|
Payments
|
Foreign
Translation
& Other Adjustments
|
July 31, 2021
|
|||||||||||||||
|
Severance and termination benefits
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|||||||
| ● |
Research Publishing & Platforms
|
| ● |
Academic & Professional Learning
|
| ● |
Education
Services
|
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Revenue:
|
||||||||
|
Research Publishing & Platforms
|
$
|
|
$
|
|
||||
|
Academic & Professional Learning
(1)
|
|
|
||||||
|
Education Services
(1)
|
|
|
||||||
|
Total revenue
|
$
|
|
$
|
|
||||
|
Adjusted Contribution to Profit:
|
||||||||
|
Research Publishing & Platforms
|
$
|
|
$
|
|
||||
|
Academic & Professional Learning
(1)
|
|
(
|
)
|
|||||
|
Education Services
(1)
|
(
|
)
|
|
|||||
|
Total adjusted contribution to profit
|
|
|
||||||
|
Adjusted corporate contribution to profit
|
(
|
)
|
(
|
)
|
||||
|
Total adjusted contribution to profit
|
$
|
|
$
|
|
||||
|
Depreciation and Amortization:
|
||||||||
|
Research Publishing & Platforms
|
$
|
|
$
|
|
||||
|
Academic & Professional Learning
(1)
|
|
|
||||||
|
Education Services
(1)
|
|
|
||||||
|
Total depreciation and amortization
|
|
|
||||||
|
Corporate depreciation and amortization
|
|
|
||||||
|
Total depreciation and amortization
|
$
|
|
$
|
|
||||
| (1) |
|
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
US GAAP Operating Income
|
$
|
|
$
|
|
||||
|
Adjustments:
|
||||||||
|
Restructuring and related (credits) charges
(1)
|
(
|
)
|
|
|||||
|
Non-GAAP Adjusted Contribution to Profit
|
$
|
|
$
|
|
||||
| (1) |
|
|
|
July 31, 2021
|
April 30, 2021
|
||||||
|
Finished goods
|
$
|
|
$
|
|
||||
|
Work-in-process
|
|
|
||||||
|
Paper and other materials
|
|
|
||||||
|
Total inventories before estimated sales returns and LIFO reserve
|
$
|
|
$
|
|
||||
|
Inventory value of estimated sales returns
|
|
|
||||||
|
LIFO reserve
|
(
|
)
|
(
|
)
|
||||
|
Inventories, net
|
$
|
|
$
|
|
||||
|
|
April 30, 2021
(1)
|
Foreign
Translation
Adjustment
|
July 31, 2021
|
|||||||||
|
Research Publishing & Platforms
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Academic & Professional Learning
|
|
(
|
)
|
|
||||||||
|
Education Services
|
|
(
|
)
|
|
||||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
| (1) |
|
|
|
July 31, 2021
|
April 30, 2021
(1)
|
||||||
|
Intangible assets with definite lives, net:
|
||||||||
|
Content and publishing rights
|
$
|
|
$
|
|
||||
|
Customer relationships
|
|
|
||||||
|
Developed technology
|
|
|
||||||
|
Brands and trademarks
|
|
|
||||||
|
Covenants not to compete
|
|
|
||||||
|
Total intangible assets with definite lives, net
|
|
|
||||||
|
Intangible assets with indefinite lives:
|
||||||||
|
Brands and trademarks
|
|
|
||||||
|
Publishing rights
|
|
|
||||||
|
Total intangible assets with indefinite lives
|
|
|
||||||
|
Total intangible assets, net
|
$
|
|
$
|
|
||||
| (1) |
|
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Service cost
|
$
|
|
$
|
|
||||
|
Interest cost
|
|
|
||||||
|
Expected return on plan assets
|
(
|
)
|
(
|
)
|
||||
|
Amortization of prior service cost
|
(
|
)
|
(
|
)
|
||||
|
Amortization of net actuarial loss
|
|
|
||||||
|
Net pension income
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
|
July 31, 2021
|
April 30, 2021
|
||||||
|
Short-term portion of long-term debt
(1)
|
$
|
|
$
|
|
||||
|
Term loan A - Amended and Restated RCA
(2)
|
|
|
||||||
|
Revolving credit facility - Amended and Restated RCA
|
|
|
||||||
|
Total long-term debt, less current portion
|
|
|
||||||
|
Total debt
|
$
|
|
$
|
|
||||
| (1) |
|
| (2) |
|
|
|
Three Months Ended
July 31, 2021
|
|||
|
Shares repurchased - Class A
|
|
|||
|
Shares repurchased - Class B
|
|
|||
|
Average price - Class A and Class B
|
$
|
|
||
|
Date of Declaration by
Board of Directors
|
Quarterly Cash Dividend
|
Total Dividend
|
Class of
Common
Stock
|
Dividend Paid
Date
|
Shareholders of
Record as of Date
|
|||||
|
|
$
|
$
|
Class A and
Class B
|
|
|
|
Changes in Common Stock A:
|
2021
|
2020
|
||||||
|
Number of shares, beginning of year
|
|
|
||||||
|
Common stock class conversions
|
|
|
||||||
|
Number of shares issued, end of period
|
|
|
||||||
|
Changes in Common Stock A in treasury:
|
||||||||
|
Number of shares held, beginning of year
|
|
|
||||||
|
Purchase of treasury shares
|
|
|
||||||
|
Restricted shares issued under stock-based compensation plans - non-PSU Awards
|
(
|
)
|
(
|
)
|
||||
|
Restricted shares issued under stock-based compensation plans - PSU Awards
|
(
|
)
|
(
|
)
|
||||
|
Restricted shares issued from exercise of stock options
|
(
|
)
|
(
|
)
|
||||
|
Shares withheld for taxes
|
|
|
||||||
|
Number of shares held, end of period
|
|
|
||||||
|
Number of Common Stock A outstanding, end of period
|
|
|
||||||
|
Changes in Common Stock B:
|
2021
|
2020
|
||||||
|
Number of shares, beginning of year
|
|
|
||||||
|
Common stock class conversions
|
(
|
)
|
(
|
)
|
||||
|
Number of shares issued, end of period
|
|
|
||||||
|
Changes in Common Stock B in treasury:
|
||||||||
|
Number of shares held, beginning of year
|
|
|
||||||
|
Purchase of treasury shares
|
|
|
||||||
|
Number of shares held, end of period
|
|
|
||||||
|
Number of Common Stock B outstanding, end of period
|
|
|
||||||
| ● |
Research Publishing & Platforms
|
| ● |
Academic & Professional Learning
|
| ● |
Education Services
|
|
Three Months Ended
July 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
US GAAP Operating Income
|
$
|
40,968
|
$
|
30,039
|
||||
|
Adjustments:
|
||||||||
|
Restructuring and related (credits) charges
|
(276
|
)
|
2,218
|
|||||
|
Non-GAAP Adjusted CTP
|
$
|
40,692
|
$
|
32,257
|
||||
|
Three Months Ended
July 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
Net Income
|
$
|
13,830
|
$
|
16,334
|
||||
|
Interest expense
|
4,639
|
4,614
|
||||||
|
Provision for income taxes
|
30,172
|
13,400
|
||||||
|
Depreciation and amortization
|
54,566
|
49,507
|
||||||
|
Non-GAAP EBITDA
|
103,207
|
83,855
|
||||||
|
Restructuring and related (credits) charges
|
(276
|
)
|
2,218
|
|||||
|
Foreign exchange transaction (gains) losses
|
(370
|
)
|
82
|
|||||
|
Gain on sale of certain assets
|
(3,750
|
)
|
—
|
|||||
|
Other income, net
|
(3,553
|
)
|
(4,391
|
)
|
||||
|
Non-GAAP Adjusted EBITDA
|
$
|
95,258
|
$
|
81,764
|
||||
|
Three Months Ended
July 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
US GAAP Income Before Taxes
|
$
|
44,002
|
$
|
29,734
|
||||
|
Pretax Impact of Adjustments:
|
||||||||
|
Restructuring and related (credits) charges
|
(276
|
)
|
2,218
|
|||||
|
Foreign exchange gains on intercompany transactions
|
(795
|
)
|
(1,569
|
)
|
||||
|
Gain on sale of certain assets
|
(3,750
|
)
|
—
|
|||||
|
Non-GAAP Adjusted Income Before Taxes
|
$
|
39,181
|
$
|
30,383
|
||||
|
Three Months Ended
July 31,
|
||||||||
|
2021
|
2020
|
|||||||
|
US GAAP Income Tax Provision
|
$
|
30,172
|
$
|
13,400
|
||||
|
Income Tax Impact of Adjustments
(1)
:
|
||||||||
|
Restructuring and related (credits) charges
|
45
|
743
|
||||||
|
Foreign exchange gains on intercompany transactions
|
(101
|
)
|
(612
|
)
|
||||
|
Gain on sale of certain assets
|
(936
|
)
|
—
|
|||||
|
Income Tax Adjustments:
|
||||||||
|
Impact of increase in UK statutory rate on deferred tax balances
(2)
|
(20,726
|
)
|
(6,689
|
)
|
||||
|
Non-GAAP Adjusted Income Tax Provision
|
$
|
8,454
|
$
|
6,842
|
||||
|
US GAAP Effective Tax Rate
|
68.6
|
%
|
45.1
|
%
|
||||
|
Non-GAAP Adjusted Effective Tax Rate
|
21.6
|
%
|
22.5
|
%
|
||||
| (1) |
For the three months ended July 31, 2021, substantially all of the tax impact was from deferred taxes. For the three months ended July 31, 2020, the tax impact was $0.2 million from current taxes offset by $0.1 million from deferred taxes.
|
| (2) |
These adjustments impacted deferred taxes in the three months ended July 31, 2021 and 2020.
|
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
US GAAP EPS
|
$
|
0.24
|
$
|
0.29
|
||||
|
Adjustments:
|
||||||||
|
Restructuring and related (credits) charges
|
(0.01
|
)
|
0.03
|
|||||
|
Foreign exchange gains on intercompany transactions
|
(0.01
|
)
|
(0.02
|
)
|
||||
|
Gain on sale of certain assets
|
(0.05
|
)
|
—
|
|||||
|
Income tax adjustments
|
0.37
|
0.12
|
||||||
|
Non-GAAP Adjusted EPS
|
$
|
0.54
|
$
|
0.42
|
||||
|
|
Three Months Ended
July 31,
|
Constant Currency
|
||||||||||||||
|
RESEARCH PUBLISHING & PLATFORMS:
|
2021
|
2020
|
% Change
Favorable
(Unfavorable)
|
% Change
Favorable
(Unfavorable)
|
||||||||||||
|
Revenue:
|
||||||||||||||||
|
Research Publishing
|
$
|
263,358
|
$
|
230,464
|
14
|
%
|
10
|
%
|
||||||||
|
Research Platforms
|
11,398
|
10,346
|
10
|
%
|
10
|
%
|
||||||||||
|
Total Research Publishing & Platforms Revenue
|
274,756
|
240,810
|
14
|
%
|
10
|
%
|
||||||||||
|
Cost of Sales
|
72,631
|
65,701
|
(11
|
)%
|
(5
|
)%
|
||||||||||
|
Operating Expenses
|
111,195
|
97,821
|
(14
|
)%
|
(10
|
)%
|
||||||||||
|
Amortization of Intangible Assets
|
11,906
|
7,667
|
(55
|
)%
|
(49
|
)%
|
||||||||||
|
Restructuring Charges (Credits) (see Note 9)
|
216
|
(197
|
)
|
#
|
#
|
|||||||||||
|
Contribution to Profit
|
78,808
|
69,818
|
13
|
%
|
10
|
%
|
||||||||||
|
Restructuring Charges (Credits) (see Note 9)
|
216
|
(197
|
)
|
#
|
#
|
|||||||||||
|
Adjusted Contribution to Profit
|
79,024
|
69,621
|
14
|
%
|
10
|
%
|
||||||||||
|
Depreciation and amortization
|
23,762
|
19,701
|
(21
|
)%
|
(18
|
)%
|
||||||||||
|
Adjusted EBITDA
|
$
|
102,786
|
$
|
89,322
|
15
|
%
|
12
|
%
|
||||||||
|
Adjusted EBITDA Margin
|
37.4
|
%
|
37.1
|
%
|
||||||||||||
|
|
Three Months Ended
July 31,
|
Constant Currency
|
||||||||||||||
|
ACADEMIC & PROFESSIONAL LEARNING:
|
2021
|
2020
|
% Change
Favorable
(Unfavorable)
|
% Change
Favorable
(Unfavorable)
|
||||||||||||
|
Revenue:
|
||||||||||||||||
|
Education Publishing
(1)
|
$
|
66,380
|
$
|
63,603
|
4
|
%
|
1
|
%
|
||||||||
|
Professional Learning
|
72,884
|
62,829
|
16
|
%
|
13
|
%
|
||||||||||
|
Total Academic & Professional Learning
|
139,264
|
126,432
|
10
|
%
|
7
|
%
|
||||||||||
|
Cost of Sales
|
42,071
|
36,482
|
(15
|
)%
|
(12
|
)%
|
||||||||||
|
Operating Expenses
|
85,246
|
86,057
|
1
|
%
|
4
|
%
|
||||||||||
|
Amortization of Intangible Assets
|
3,624
|
4,138
|
12
|
%
|
14
|
%
|
||||||||||
|
Restructuring Charges (see Note 9)
|
171
|
33
|
#
|
#
|
||||||||||||
|
Contribution to Profit
|
8,152
|
(278
|
)
|
#
|
#
|
|||||||||||
|
Restructuring Charges (see Note 9)
|
171
|
33
|
#
|
#
|
||||||||||||
|
Adjusted Contribution to Profit
|
8,323
|
(245
|
)
|
#
|
#
|
|||||||||||
|
Depreciation and amortization
|
18,364
|
18,804
|
2
|
%
|
5
|
%
|
||||||||||
|
Adjusted EBITDA
|
$
|
26,687
|
$
|
18,559
|
44
|
%
|
37
|
%
|
||||||||
|
Adjusted EBITDA Margin
|
19.2
|
%
|
14.7
|
%
|
||||||||||||
| (1) |
In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning – Education Publishing to Education Services – Talent Development Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services - Talent Development Services. The Revenue, Adjusted Contribution to Profit and Adjusted EBITDA for WileyNXT was $0.5 million, $0.1 million, and $0.1 million, respectively, for the three months ended July 31, 2020. There were no changes to our total consolidated financial results.
|
|
|
Three Months Ended
July 31,
|
Constant Currency
|
||||||||||||||
|
EDUCATION SERVICES:
|
2021
|
2020
|
% Change
Favorable
(Unfavorable)
|
% Change
Favorable
(Unfavorable)
|
||||||||||||
|
Revenue:
|
||||||||||||||||
|
University Services
(1)
|
$
|
54,394
|
$
|
50,262
|
8
|
%
|
8
|
%
|
||||||||
|
Talent Development Services
(2)(3)
|
19,974
|
13,822
|
45
|
%
|
34
|
%
|
||||||||||
|
Total Education Services Revenue
|
74,368
|
64,084
|
16
|
%
|
13
|
%
|
||||||||||
|
Cost of Sales
|
51,252
|
42,625
|
(20
|
)%
|
(17
|
)%
|
||||||||||
|
Operating Expenses
|
19,355
|
15,777
|
(23
|
)%
|
(20
|
)%
|
||||||||||
|
Amortization of Intangible Assets
|
5,622
|
5,087
|
(11
|
)%
|
(9
|
)%
|
||||||||||
|
Restructuring (Credits) Charges (see Note 9)
|
(34
|
)
|
139
|
#
|
#
|
|||||||||||
|
Contribution to Profit
|
(1,827
|
)
|
456
|
#
|
#
|
|||||||||||
|
Restructuring (Credits) Charges (see Note 9)
|
(34
|
)
|
139
|
#
|
#
|
|||||||||||
|
Adjusted Contribution to Profit
|
(1,861
|
)
|
595
|
#
|
#
|
|||||||||||
|
Depreciation and amortization
|
8,303
|
7,279
|
(14
|
)%
|
(13
|
)%
|
||||||||||
|
Adjusted EBITDA
|
$
|
6,442
|
$
|
7,874
|
(18
|
)%
|
(21
|
)%
|
||||||||
|
Adjusted EBITDA Margin
|
8.7
|
%
|
12.3
|
%
|
||||||||||||
| (1) |
University Services was previously referred to as Education Services OPM.
|
| (2) |
Talent Development Services was previously referred to as mthree.
|
| (3) |
In May 2021, we moved the WileyNXT product offering from Academic & Professional Learning – Education Publishing to Education Services – Talent Development Services. As a result, the prior period results related to the WileyNXT product offering have been included in Education Services - Talent Development Services. The Revenue, Adjusted Contribution to Profit and Adjusted EBITDA for WileyNXT was $0.5 million, $0.1 million, and $0.1 million, respectively, for the three months ended July 31, 2020. There were no changes to our total consolidated financial results.
|
|
Metric
|
Fiscal Year 2021
Actual
|
Fiscal Year 2022
Outlook
|
||||||
|
Revenue
|
$
|
1,942
|
$
|
$2,070 to $2,100
|
||||
|
Adjusted EBITDA
|
$
|
419
|
$
|
$415 to $435
|
||||
|
Adjusted EPS - former
|
$
|
2.92
|
$
|
$2.80 to $3.05
|
||||
|
Adjusted EPS -newly defined
|
$
|
4.00
|
$
|
$4.00 to $4.25
|
||||
|
Free Cash Flow
|
$
|
257
|
$
|
$200 to $220
|
||||
| ● |
Revenue Outlook:
Wiley expects consolidated revenue growth of mid-to-high single digits, to a range of $2.07 to $2.1 billion.
|
| ● |
Adjusted EBITDA Outlook:
Wiley expects a range between $415 and $435 million, with profit gains on higher revenue tempered by investments to accelerate growth initiatives.
|
| ● |
Adjusted EPS Outlook (newly defined):
Wiley expects a
range between $4.00 to $4.25 reflecting investments, and a higher effective tax rate. Again, this is a reaffirmation of guidance but now excludes the non-cash amortization of acquired intangible assets totaling $1.20 per share.
|
| ● |
Free Cash Flow Outlook:
Wiley expects a range between $200 and $220 million. While cash earnings are expected to be strong, we see certain one-time headwinds compared to Fiscal Year 2021, including higher capital expenditures, higher net cash taxes, and higher annual incentive compensation payments for Fiscal Year 2021 outperformance.
|
|
Three Months Ended
July 31,
|
Fiscal Year
|
Fiscal Year
|
||||||||||||||
|
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
|
US GAAP Earnings (Loss) Per Share
|
$
|
0.24
|
$
|
0.29
|
$
|
2.63
|
$
|
(1.32
|
)
|
|||||||
|
Adjustments:
|
||||||||||||||||
|
Restructuring and related (credits) charges
|
(0.01
|
)
|
0.03
|
0.44
|
0.43
|
|||||||||||
|
Foreign exchange (gains) losses on intercompany transactions
|
(0.01
|
)
|
(0.02
|
)
|
(0.02
|
)
|
0.02
|
|||||||||
|
Gain on sale of certain assets
|
(0.05
|
)
|
—
|
—
|
—
|
|||||||||||
|
Income tax adjustments
|
0.37
|
0.12
|
(0.13
|
)
|
(0.03
|
)
|
||||||||||
|
Impairment of goodwill
|
—
|
—
|
—
|
1.94
|
||||||||||||
|
Impairment of Blackwell trade name
|
—
|
—
|
—
|
1.31
|
||||||||||||
|
Impairment of developed technology intangible
|
—
|
—
|
—
|
0.04
|
||||||||||||
|
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation
(1)
|
—
|
—
|
—
|
0.01
|
||||||||||||
|
Non-GAAP Adjusted EPS (Previously Reported)
|
$
|
0.54
|
$
|
0.42
|
$
|
2.92
|
$
|
2.40
|
||||||||
|
Amortization of acquired intangible assets
|
0.31
|
0.25
|
1.08
|
0.90
|
||||||||||||
|
Non-GAAP Adjusted EPS (Newly Defined)
|
$
|
0.85
|
$
|
0.67
|
$
|
4.00
|
$
|
3.30
|
||||||||
|
Weighted average number of common shares outstanding
|
||||||||||||||||
|
Diluted (shares in 000's)
(1)
|
56,599
|
56,193
|
56,461
|
56,729
|
||||||||||||
| (1) |
For Fiscal Year 2020, represents the impact of using diluted weighted-average number of common shares outstanding (56.7 million shares for the year ended April 30, 2020) included in the Non-US GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.
|
|
Three Months Ended
July 31,
|
Fiscal Year
|
Fiscal Year
|
||||||||||||||
|
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
|
US GAAP Income (Loss) Before Taxes
|
$
|
44,002
|
$
|
29,734
|
$
|
175,912
|
$
|
(63,092
|
)
|
|||||||
|
Pretax Impact of Adjustments:
|
||||||||||||||||
|
Restructuring and related (credits) charges
|
(276
|
)
|
2,218
|
33,310
|
32,607
|
|||||||||||
|
Foreign exchange (gains) losses on intercompany transactions
|
(795
|
)
|
(1,569
|
)
|
(1,457
|
)
|
1,256
|
|||||||||
|
Gain on sale of certain assets
|
(3,750
|
)
|
—
|
—
|
—
|
|||||||||||
|
Impairment of goodwill
|
—
|
—
|
—
|
110,000
|
||||||||||||
|
Impairment of Blackwell trade name
|
—
|
—
|
—
|
89,507
|
||||||||||||
|
Impairment of developed technology intangible
|
—
|
—
|
—
|
2,841
|
||||||||||||
|
Non-GAAP Adjusted Income Before Taxes (Previously Reported)
|
$
|
39,181
|
$
|
30,383
|
$
|
207,765
|
$
|
173,119
|
||||||||
|
Amortization of acquired intangible assets
|
22,284
|
18,149
|
79,421
|
68,269
|
||||||||||||
|
Non-GAAP Adjusted Income Before Taxes (Newly Defined)
|
$
|
61,465
|
$
|
48,532
|
$
|
287,186
|
$
|
241,388
|
||||||||
|
Three Months Ended
July 31,
|
Fiscal Year
|
Fiscal Year
|
||||||||||||||
|
|
2021
|
2020
|
2021
|
2020
|
||||||||||||
|
US GAAP Income Tax Provision
|
$
|
30,172
|
$
|
13,400
|
$
|
27,656
|
$
|
11,195
|
||||||||
|
Income Tax Impact of Adjustments
(1)
:
|
||||||||||||||||
|
Restructuring and related (credits) charges
|
45
|
743
|
8,065
|
7,949
|
||||||||||||
|
Foreign exchange (gains) losses on intercompany transactions
|
(101
|
)
|
(612
|
)
|
(363
|
)
|
242
|
|||||||||
|
Gain on sale of certain assets
|
(936
|
)
|
—
|
—
|
—
|
|||||||||||
|
Impairment of Blackwell trade name
|
—
|
—
|
—
|
15,216
|
||||||||||||
|
Impairment of developed technology intangible
|
—
|
—
|
—
|
686
|
||||||||||||
|
Income Tax Adjustments:
|
||||||||||||||||
|
Impact of increase in UK statutory rate on deferred tax balances
(2)
|
(20,726
|
)
|
(6,689
|
)
|
(3,511
|
)
|
—
|
|||||||||
|
Impact of US CARES Act
(3)
|
—
|
—
|
13,998
|
—
|
||||||||||||
|
Impact of change in certain US state tax rates in 2021 and tax rates in France in 2020
(2)
|
—
|
—
|
(3,225
|
)
|
1,887
|
|||||||||||
|
Non-GAAP Adjusted Income Tax Provision (Previously Reported)
|
$
|
8,454
|
$
|
6,842
|
$
|
42,620
|
$
|
37,175
|
||||||||
|
Amortization of acquired intangible assets
(1)
|
4,843
|
4,298
|
18,511
|
16,820
|
||||||||||||
|
Non-GAAP Adjusted Income Tax Provision (Newly Defined)
|
$
|
13,297
|
$
|
11,140
|
$
|
61,131
|
$
|
53,995
|
||||||||
|
US GAAP Effective Tax Rate
|
68.6
|
%
|
45.1
|
%
|
15.7
|
%
|
(17.7
|
)%
|
||||||||
|
Non-GAAP Adjusted Effective Tax Rate (Previously Reported)
|
21.6
|
%
|
22.5
|
%
|
20.5
|
%
|
21.5
|
%
|
||||||||
|
Non-GAAP Adjusted Effective Tax Rate (Newly Defined)
|
21.6
|
%
|
23.0
|
%
|
21.3
|
%
|
22.4
|
%
|
||||||||
| (1) |
These adjustments substantially impacted deferred taxes.
|
| (2) |
These adjustments impacted deferred taxes.
|
| (3) |
The tax impact was $8.4 million from current taxes and $5.6 million from deferred taxes in the year ended April 30, 2021.
|
|
Fiscal Year
|
||||
|
2021
|
||||
|
Net Income
|
$
|
148,256
|
||
|
Interest expense
|
18,383
|
|||
|
Provision for income taxes
|
27,656
|
|||
|
Depreciation and amortization
|
200,189
|
|||
|
Non-GAAP EBITDA
|
394,484
|
|||
|
Restructuring and related charges
|
33,310
|
|||
|
Foreign exchange transaction losses
|
7,977
|
|||
|
Other income, net
|
(16,761
|
)
|
||
|
Non-GAAP Adjusted EBITDA
|
$
|
419,010
|
||
|
Fiscal Year
|
||||
|
2021
|
||||
|
Net cash provided by operating activities
|
$
|
359,923
|
||
|
Less: Additions to technology, property and equipment
|
(77,407
|
)
|
||
|
Less: Product development spending
|
(25,954
|
)
|
||
|
Free cash flow less product development spending
|
$
|
256,562
|
||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Net cash used in operating activities
|
$
|
(84,774
|
)
|
$
|
(120,783
|
)
|
||
|
Net cash used in investing activities
|
(23,532
|
)
|
(28,280
|
)
|
||||
|
Net cash provided by financing activities
|
99,089
|
43,484
|
||||||
|
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash
|
$
|
(1,586
|
)
|
$
|
4,500
|
|||
|
|
Three Months Ended
July 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Net cash used in operating activities
|
$
|
(84,774
|
)
|
$
|
(120,783
|
)
|
||
|
Less: Additions to technology, property and equipment
|
(17,910
|
)
|
(18,964
|
)
|
||||
|
Less: Product development spending
|
(5,670
|
)
|
(5,325
|
)
|
||||
|
Free cash flow less product development spending
|
$
|
(108,354
|
)
|
$
|
(145,072
|
)
|
||
|
Net cash used in
operating activities – Three months ended July 31, 2020
|
$
|
(120.8
|
)
|
|
|
Net income adjusted for items to reconcile net income to net cash used in operating activities, including the following noncash items: depreciation and amortization, and the change in deferred taxes
|
12.5
|
|||
|
Working capital changes:
|
|
|||
|
Accounts payable and royalties payable
|
36.0
|
|||
|
Income taxes
|
20.2
|
|||
|
Other accrued liabilities
|
(37.7
|
)
|
||
|
Accounts receivable, net and contract liabilities
|
(6.4
|
)
|
||
|
Other working capital items
|
11.4
|
|||
|
Net cash used in operating activities – Three months ended July 31, 2021
|
$
|
(84.8
|
)
|
|
Three Months Ended
July 31, 2021
|
||||
|
Shares repurchased – Class A
|
129
|
|||
|
Shares repurchased – Class B
|
1
|
|||
|
Average price – Class A and Class B
|
$
|
56.88
|
||
|
|
July 31, 2021
|
April 30, 2021
|
||||||
|
Increase in Inventories, net
|
$
|
11,047
|
$
|
10,886
|
||||
|
Decrease in Accrued royalties
|
$
|
(5,342
|
)
|
$
|
(4,949
|
)
|
||
|
Increase in Contract liabilities
|
$
|
40,694
|
$
|
38,034
|
||||
|
Print book sales return reserve net liability balance
|
$
|
(24,305
|
)
|
$
|
(22,199
|
)
|
||
|
Total Number
of Shares
Purchased
|
Average
Price Paid
Per Share
|
Total Number
of Shares Purchased
as part of a Publicly
Announced Program
|
Maximum Number
of Shares that May
be Purchased
Under the Program
|
Maximum Dollar
Value of Shares
that May be Purchased
Under Additional Plans or Programs
(Dollars in millions)
|
||||||||||||||||
|
May 2021
|
—
|
$
|
—
|
—
|
497,197
|
$
|
200
|
|||||||||||||
|
June 2021
|
75,513
|
56.49
|
75,513
|
421,684
|
200
|
|||||||||||||||
|
July 2021
|
54,000
|
57.43
|
54,000
|
367,684
|
200
|
|||||||||||||||
|
Total
|
129,513
|
$
|
56.88
|
129,513
|
367,684
|
$
|
200
|
|||||||||||||
|
Material Contracts
|
|
|
Separation and Release Agreement, dated June 11, 2021 between Matthew S. Kissner, Group Executive Vice President, and the Company (incorporated by reference to the Company’s Report on Form 8-K filed on June 17, 2021).
|
|
|
Transition and Consulting Agreement, dated June 15, 2021 between Matthew S. Kissner, Group Executive Vice President, and the Company (incorporated by reference to the Company’s Report on Form 8-K filed on June 17, 2021).
|
|
|
Restricted Share Unit Grant Agreement under the Executive Long-Term Incentive Plan Pursuant to the 2014 Key Employee Stock Plan.
|
|
|
Performance Share Unit Grant Agreement under the Executive Long-Term Incentive Plan Pursuant to the 2014 Key Employee Stock Plan.
|
|
|
Non-Qualified Premium Stock Option Grant Agreement Pursuant to the 2014 Key Employee Stock Plan.
|
|
|
Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
Inline XBRL
|
|
|
101.INS*
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
|
|
101.SCH*
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
101.CAL*
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF*
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB*
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE*
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
|
JOHN WILEY & SONS, INC.
|
|||
|
Registrant
|
|||
|
By
|
/s/ Brian A. Napack
|
||
|
Brian A. Napack
|
|||
|
President and Chief Executive Officer
|
|||
|
By
|
/s/ John A. Kritzmacher
|
||
|
John A. Kritzmacher
|
|||
|
Executive Vice President and Chief Financial Officer
|
|||
|
By
|
/s/ Christopher F. Caridi
|
||
|
Christopher F. Caridi
|
|||
|
Senior Vice President, Global Corporate Controller and Chief Accounting Officer
|
|||
|
Dated: September 3, 2021
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|